Photothermal Therapy via a Gold Nanoparticle-Coated Stent for Treating Stent-Induced Granulation Tissue Formation in the Rat Esophagus

doi:10.21203/rs.3.rs-133808/v1

Download PDF

Research Article

Photothermal Therapy via a Gold Nanoparticle-Coated Stent for Treating Stent-Induced Granulation Tissue Formation in the Rat Esophagus

https://doi.org/10.21203/rs.3.rs-133808/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Minimally invasive therapies using stent technology are currently limited by stent-induced granulation tissue formation adjacent to the stent. The effectiveness of photothermal therapy (PTT) using a gold nanoparticle (AuNP)-coated stent for treating stent-induced granulation tissue formation in the rat esophagus was investigated. All experiments were approved by the animal research committee of our institution. An AuNP-coated, self-expandable metallic stent (SEMS) was produced to conduct PTT under near-infrared laser irradiation. Forty rats were randomly divided into four groups (10 rats each). The animals in group A (non-coated SEMS) and group B (AuNP-coated SEMS with local heating at 65°C at 4 weeks) were sacrificed 4 weeks after stent placement. The rats in group C (AuNP-coated SEMS with local heating at 65°C at 4 weeks) and group D (AuNP-coated SEMS with local heating at 65°C at 4 and 8 weeks) were sacrificed 8 weeks after stent placement. The effectiveness of local heating was assessed by histopathology. All procedures were successful in all of the animals. Seven rats were excluded because of stent migration (n = 2) and death (n = 5). Granulation tissue formation-related variables were significantly higher in group A than in groups B-D (all p < 0.05). HSP70 and TUNEL expression were significantly lower in group A than in groups B-D (all p < 0.05). Granulation tissue formation-related variables were significantly higher in group C than in groups B and D (all p < 0.05). PTT using AuNP-coated SEMS successfully treated granulation tissue formation after stent placement in the rat esophagus.

Gastroenterology & Hepatology

Nanoscience

Biomedical Engineering

Stent

gold nanoparticle

photothermal therapy

granulation tissue

esophageal stricture

Esophageal stenting using a self-expandable metallic stent (SEMS) is currently the most common therapeutic strategy for treating malignant and benign diseases.^1-3 The use of SEMS devices is significantly limited however by malignant and/or benign tissue growth through the stent meshes after placement, which can lead to newly developed stricture formation and recurrent symptoms.^2-5 Drug-eluting, biodegradable, and nano-functionalized stents have been investigated as possible avenues to overcome this complication but have not been successful in treating stent-induced malignant and/or benign tissue formation.^6-12

Photothermal therapy (PTT) offers a potential therapeutic strategy for cancer cells without significant collateral damage.^{13, 14} Gold nanoparticles (AuNPs) have excellent absorption properties in the near-infrared (NIR) spectrum of biological window and their PT-converting efficiency has been studied previously as a possible biomedical application for targeting different diseases.^13-18 Recently, AuNP-based functionalized stents were introduced to locally treat cancer cells or tissue hyperplasia adjacent to stented non-vascular luminal organs.^{11, 12, 19, 20} Park et al. have reported in rat models that locally applied temperature increases (50°C to 65°C) successfully suppressed tissue hyperplasia after esophageal and gastroduodenal stent placement.^{11, 20} We hypothesized that AuNP-coated SEMS could be used for localized PTT under NIR laser irradiation. We speculated that this approach would treat stent-induced granulation tissue formation after SEMS placement through the induction of PT-induced cell apoptosis and activation of heat-shock proteins (HSPs). We here investigated the feasibility of this therapy in the rat esophagus.

Study design

The Institutional Animal Care and Use Committee of the Asan Institute for Life Sciences (Seoul, Korea) approved all of the experiment protocols and animals used in this study (2019-13-056). All experiments were performed in accordance with relevant guidelines and regulations. The study was carried out in compliance with the ARRIVE guidelines. The number of animals was prospectively calculated according to the previous report.⁶ In total, 40 Sprague-Dawley male rats (300–350 g; Orient Bio, Seongnam, Korea) underwent SEMS placement into the esophagus. AuNP-coated SEMSs were prepared as described previously.^{11, 20} The animals were divided into four groups. Group A (n = 10) received non-coated SEMS. Group B (n = 10) received AuNP-coated SEMS with local heating at 65 °C at 4 weeks. All rats in groups A and B were sacrificed 4 weeks after stent placement. Two additional groups were included to evaluate any rebound effects of local heating. Group C (n = 10) received AuNP-coated SEMS with local heating at 65 °C at 4 weeks. Group D (n = 10) received AuNP-coated SEMS with local heating at 65 °C at both 4 and 8 weeks. All rats in groups C and D were sacrificed 8 weeks after SEMS placement for histopathological analysis (Fig. 1). All animals were sacrificed by administering inhalable pure dioxide. The body weight of each rat was measured weekly until they were sacrificed. All animals were housed at one per cage in a room with a 12-hour contrast cycle at 24 ± 1 °C with a relative humidity of 55 ± 10%. Standard rodent chow and water were provided ad libitum. All animals were acclimated for at least 1 week prior to conducting the experiments.

Stent placement in the rat esophagus

For stent placements in the esophagus, the rats were anesthetized via an intramuscular injection of 50 mg/kg zolazepam and 50 mg/kg tiletamine (Zoletil 50; Virbac, Carros, France) and 10 mg/kg xylazine (Rompun; Bayer HealthCare, Leverkusen, Germany). A 0.014-inch guidewire (Transcend; Boston Scientific, Watertown, MA) was inserted through the mouth and negotiated into the stomach under fluoroscopic guidance. A customized 6-Fr sheath and dilator were then advanced into the lower esophagus through the guide wire. With the sheath left in place, the dilator and the guidewire were removed. A stent in a compressed state was loaded into the sheath and placed in the esophagus using a pusher catheter. The stent was deployed at the level of the mid-thoracic esophagus under continuous fluoroscopic monitoring.

Photothermal therapy under near-infrared irradiation

PTT under NIR irradiation was performed at both 4 weeks (groups B, C, and D) and 8 weeks (group D) after stent placement in the experimental rats. For NIR laser irradiation during the in vivo fluoroscope-guided procedure, a 1-mm diameter fiber-coupled NIR (808 nm) diode-laser (OCLA^™ LASER, NDLUX Inc., Anyang, Korea) was inserted into a 6-Fr sheath with a radiopaque tip for visualization by fluoroscopy. Using fluoroscopic guidance, the sheath and optic fiber were advanced through the mouth into the middle portion of the stented esophagus. NIR laser irradiation was applied for 60 seconds in all rats. After stent placement and local heating, all animals were intramuscularly injected with 0.05 mg/kg of buprenorphine (Renophan; Hanlim Pharmaceutical, Seoul, Korea) every 6 hours for pain control for 48 hours. All animals were monitored until recovery from anesthesia and were then returned to their cages.

Histological analysis

Surgical exploration of the entire esophagus and stomach was followed by gross examination to determine possible esophageal injury after stent placement or irradiation. Tissue samples were fixed in 10% neutral buffered formalin for 24 hours, then embedded in paraffin and sectioned. The stented esophagus was sectioned transversely in the middle area. The slides were stained with hematoxylin and eosin (H&E) and Masson’s trichrome (MT). Histological evaluation using H&E was based on the degree of submucosal inflammatory cell infiltration, the number of epithelial layers, the thickness of the submucosal fibrosis, and the tissue-hyperplasia-related percentage of the esophageal cross-sectional area of stenosis calculated as 100 × (1 − [stenotic stented area/original stented area]).^{6, 11} The degree of inflammatory cell infiltration was subjectively determined according to the distribution and density of the inflammatory cells, i.e. graded as 1, mild when there was occasional visible infiltration of single leukocytes; 2, mild-to-moderate when there was patchy infiltration of leukocytes; 3, moderate when coalescing leukocytes made individual loci indistinguishable; 4, moderate-to-severe when there was diffuse infiltration of leukocytes throughout the submucosal layer; and 5, severe when there was diffuse infiltration with multiple necrotic foci.²¹ The collagen-deposition level was subjectively determined with the following scores: 1 = mild, 2 = mild to moderate, 3 = moderate, 4 = moderate to severe, and 5 = severe. The esophagus was analyzed histologically using a BX51 microscope (Olympus, Tokyo, Japan). Image-Pro Plus software (Media Cybernetics, Silver Spring, MD) was used for the measurements. The histological findings were based on the consensus of three observers who were blind to the experimental groups.

Immunohistochemistry

Immunohistochemistry was performed on paraffin-embedded sections using TUNEL (Apoptotag kit, Biogene, Darmstadt, Germany) and HSP70 (1:1000; Abcam, Cambridge, UK) primary antibodies. The sections were visualized using a BenchMark XT IHC automated immunohistochemical stainer (Ventana Medical Systems, Tucson, AZ). The degree of TUNEL and HSP70 positive deposition was determined subjectively (1 = mild, 2 = mild to moderate, 3 = moderate, 4 = moderate to severe, and 5 = severe). IHC findings were also based on the consensus of three observers of three observers who were blind to the experimental groups.

Statistical analysis

Data were expressed as a mean ± standard deviation (SD). Differences between the groups were analyzed using Kruskal–Wallis or Mann–Whitney U test, as appropriate. A p-value of < 0.05 was considered statistically significant. Statistical analyses were performed using SPSS software (version 24.0; SPSS, IBM, Chicago, IL).

Stent placement and PT-mediated local heating

Stent placement and PTT were technically successful in all the experimental rats. Five of 40 (12.5%) rats (one each in groups A-C and two in group D) died after stent placement due to a hemorrhage caused by the stent barbs at 1–3 days after placement. The AuNP-coated SEMS migrated into the stomach in two rats (one each in groups A and C) within 10 days of placement. The remaining 33 (82.5%) rats survived until the end of the study without stent-related complications (Fig. 2).

Although the body weights of the rats decreased at 1 week after stent placement and the PTT procedure, this did not significantly affect any of these animals in terms of their condition and behavior. There were also no significant differences between the groups in terms of the body weights after stent placement and the PTT procedure (p > 0.05) (Supplementary Fig. 1).

Histological findings

The mean percentage of the tissue-hyperplasia area, the mean thickness of the submucosal fibrosis, the mean number of epithelial layers, the mean degree of the collagen deposition, and the mean degree of TUNEL- and HSP70-positive deposition were significantly different between the groups (all variables, p < 0.001, Kruskal–Wallis test). The mean percentage of tissue-hyperplasia area, mean number of epithelial layers, mean thickness of submucosal fibrosis, and mean degree of collagen deposition were significantly higher in group A than in groups B-D (all variables; p < 0.05) (Fig. 3). However, the mean degrees of HSP70- and TUNEL-positive-deposition were significantly lower in group A than in groups B-D (all variables; p < 0.05) (Fig. 4). The density grade of inflammatory cell infiltration was not significantly different among the four groups (p = 0.726, Kruskal-Wallis test). The mean tissue-hyperplasia area and number of epithelial layers were significantly higher in group C than in groups B and D (all variables; p < 0.05). The mean degree of HSP70-positive-deposition was significantly lower in group C than in groups B and D (all variables; p < 0.05) (Fig. 5). These histological findings are summarized in Supplementary Table 1.

Our present results have demonstrated that PTT via an AuNP-coated SEMS under NIR laser irradiation will successfully treat granulation tissue formation after stent placement in the rat esophagus. The granulation tissue was significantly decreased in the PTT groups compared to a control group. PTT-induced cell apoptosis was significantly elevated in the heated esophageal mucosa, and markers of cellular proliferation were significantly decreased after PTT when compared to the control animals. Increases in HSP expression and thermal induced-apoptosis are well-characterized features of the heat shock response, and previous studies have reported that HSP70 is an indicator of heat stress in different species.^{22, 23}

Our study groups were evaluated for the rebound effect. The group C rats treated once at 4 weeks after stent placement had a significant increase in granulation tissue formation at 8 weeks compared to the group D animals treated twice at 4 and 8 weeks after stent placement. The tissue-hyperplasia area and number of epithelial layers in group C were found to have gradually increased compared with the group D rats. Our results confirmed that the PTT was more effective when administered every 4 weeks and indicated therefore that periodic PTT seems to be necessary to treat stent-induced granulation tissue formation after stent placement. Further studies with a long-term follow-up are required to confirm our present findings.

Although PTT has been previously reported to successfully treat granulation tissue formation, there is no consensus regarding the optimal temperature for local heating for the treatment of stent-induced granulation tissue formation.^{11, 20, 24–26} Several studies have reported that at 43 °C to 65 °C can help inhibit tissue hyperplasia but that an increase to 70 °C induced immediate tissue burn.^{11, 19, 25} In our current study, stent-induced granulation tissue formation in the rat esophagus was effectively treated with AuNP coated SEMS-mediated local heating at 65 °C, which may effectively burn the granulation tissues generated around the stent. Taken together, our present results demonstrated that local heat treatment at 65 °C was optimal for successful PTT.

Our previous studies have reported that an AuNP-coated SEMS can be easily fabricated using simple synthesis steps and is rapidly heated to therapeutic temperatures within a few seconds of NIR laser irradiation.^{11, 20} The AuNP-coated SEMS used in our current experiments thus rapidly reached a high temperature, which increased in proportion to the NIR power. Hence, the PT properties could be easily controlled by adjusting the NIR irradiation levels. These properties can be attributed to the anisotropic structural characteristics of AuNP, consistent with our prior results.^{11, 20} Our previous studies involved local heat treatment via the AuNP-coated stent under NIR irradiation at one week after stent placement to prevent stent-induced tissue hyperplasia. In our current study, local heat treatment was performed at 4 weeks after granulation tissue formation had already occurred. Restenosis caused by stent-induced granulation tissue formation occurs as an excessive proliferative response within 4 weeks to the mechanical injury caused by stent placement.^{10, 11, 21} Taken together with previous evidence, our current findings support the notion that local heat treatment via the NIR irradiation of an AuNP-coated stent is an effective therapeutic option for the prevention as well as the treatment of granulation tissue formation after stent placement.

Advances in stent technologies have resulted in a decrease in complications and a prolonged stent patency period. Although a stent has been commonly used as a minimally invasive method to treat malignant and benign esophageal strictures, tissue hyperplasia through the mesh or around the edges of esophageal stents has been reported after the placement of up to 60% of bare stents and 13% of covered stents.^{27 – 29} Hence, permanent stent placement in patients with a relatively long life expectancy has not yet become widespread due to the likelihood of late adverse events, including the development of new strictures caused by stent-induced granulation tissue formation, stent migration, and esophageal ulceration.^{30, 31} We believe however that our therapeutic strategy using AuNP-coated SEMS could be applied also to an uncovered SEMS to treat granulation tissue growth, and may prolong stent patency by reducing stent-induced tissue hyperplasia, thus improving the patients' quality of life.

There were some limitations to our study of note. First, our findings may not reflect all of the pathological mechanisms occurring in humans following a stent placement. Second, it is necessary to determine the optimal timing for local heating after stent placement to treat stent-induced granulation tissue formation. Third, we did not evaluate the depth penetration of the AuNP-coated SEMS in the rat esophageal model. Although additional studies will be required to further validate our current data, our study supports the premise that PTT via an AuNP-coated stent can successfully treated stent-induced tissue hyperplasia.

An AuNP-coated SEMS appears to be an effective approach for the local treatment of stent-induced granulation tissue formation in the rat esophagus. An AuNP-coated stent-mediated local PTT protocol could be used for not only to treat granulation tissue formation but also tumor ingrowth or overgrowth though the stent meshes. Although further preclinical studies are needed to investigate its efficacy and safety, this therapeutic strategy shows considerable promise for the treatment of granulation tissue formation after stent placement.

Acknowledgments: This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, the Ministry of Food and Drug Safety) (Project Number: 202011D16)

Competing Interests: The authors declare no competing financial and/or non-financial interests.

Author Contributions: J.-H.P., D.-H.K., and D.H.K. conceptualized the project and designed the experiments. J.-H.P., Y.C.C., W. P., and J.M.K. conducted the experimental work. Y.C.C., J.M.K., J.H.S, and J.-H, P. collected and analysed the data, and prepared the manuscript. Y.C.C., J.M.K, W.P., D.-H.K., J.H.S, D.H.K., and J.-H.P. wrote the manuscript. The final manuscript was reviewed and approved by all authors.

Keymling, M. et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N. Engl. J. Med. 329, 1302–1307 (1993).
Sharma, P. et al. Role of esophageal stents in benign and malignant diseases. Am. J. Gastroenterol. 105, 258–274 (2010).
Park, J. H. et al. Polytetrafluoroethylence-covered Retrievable Expandable Nitinol Stents for Malignant Esophageal Obstructions: Factors Influencing the Outcome of 270 Patients. AJR. Am. J. Roentgenol. 199, 1380–1386 (2012).
Kim, J. H. et al. Temporary metallic stent placement in the treatment of refractory benign esophageal strictures: results and factors associated with outcome in 55 patients. Eur. Radiol. 19, 384–390 (2009).
Park, J. H. et al. Temporary stent placement with concurrent chemoradiation therapy in patients with unresectable esophageal carcinoma: Is there an optimal time for stent removal?. Eur. Radiol. 23, 1940–1945 (2013).
Jun, E. J. et al. EW-7197, an activin-like kinase 5 inhibitor, suppresses granulation tissue after stent placement in rat esophagus. Gastrointest. Endosc. 86, 219–228 (2017).
Repici, A. et al. Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest. Endosc. 72, 927–934 (2010).
Baron, T. H. et al. An internally covered (lined) self-expanding metal esophageal stent: tissue response in a porcine model. Gastrointest. Endosc. 64, 263–267 (2006).
Jeon, S. R. et al. Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study. Endoscopy. 41, 449–456 (2009).
Kim, E. Y. et al. IN-1233-eluting covered metallic stent to prevent hyperplasia: experimental study in a rabbit esophageal model. Radiology. 267, 396–404 (2013).
Park, J. H. et al. Nanofunctionalized Stent-Mediated Local Heat Treatment for the Suppression of Stent-Induced Tissue Hyperplasia. ACS. Appl. Mater. Interfaces. 10, 29357–29366 (2018).
Lee, S. et al. On-Demand Drug Release from Gold Nanoturf for a Thermo- and Chemotherapeutic Esophageal Stent. ACS. nano. 12, 6756–6766 (2018).
Riley, R. S. et al. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley. Interdiscip. Rev. Nanomed. Nanobiotechnol. 9, 101002 (2017).
Zou, L. et al. Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics. Theranostics. 6, 762–772 (2016).
Cai, W. et al. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. Appl. 1, 17–32 (2008).
Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer. 5, 161–171 (2005).
Hirsch, L. R. et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. U. S. A. 100, 13549–13554 (2003).
Park, W. et al. Branched Gold Nanoparticle Coating of Clostridium novyi-NT Spores for CT-Guided Intratumoral Injection. Small. 13, https://doi.org/10.1002/smll.201602722 (2017).
Song, J. et al. New Generation of Gold Nanoshell-Coated Esophageal Stent: Preparation and Biomedical Applications. ACS. Appl. Mater. Interfaces. 8, 27523–27529 (2016).
Park, J. H. et al. Local Heat Treatment for Suppressing Gastroduodenal Stent-induced Tissue Hyperplasia Using Nano-functionalized Self-expandable Metallic Stent in Rat Gastric Outlet Model. ACS. Biomater. Sci. Eng. 6, 2450–2458 (2020).
Park, J. H. et al. Balloon-Expandable Biodegradable Stents Versus Self-Expandable Metallic Stents: A Comparison Study of Stent-Induced Tissue Hyperplasia in the Rat Urethra. Cardiovasc. Intervent. Radiol. 42, 1343–1351 (2019).
Kamanga-Sollo, E. et al. Effects of heat stress on proliferation, protein turnover, and abundance of heat shock protein messenger ribonucleic acid in cultured porcine muscle satellite cells. J. Anim. Sci. 89, 3473–3480 (2011).
Furusawa, Y. et al. Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress. Apoptosis. 17, 102–112 (2012).
Chu, K. F. et al. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat. Rev. Cancer. 14, 199–208 (2014).
Landsberg, R. et al. Laser-induced hyperthermia for treatment of granulation tissue growth in rats. Otolaryngol. Head. Neck. Surg. 140, 480–486 (2009).
Brasselet, C. et al. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study. Eur. Heart. J. 29, 402–412 (2008).
Song, H. Y. et al. Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology. 193, 689–695 (1994).
Shin, J. H. et al. Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma. J. Vasc. Interv. Radiol. 16, 67–74 (2005).
Wang, M. Q. et al. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J. Vasc. Interv. Radiol. 12, 465–474 (2001).
Cwikiel, W. et al. Self-expanding stent in the treatment of benign esophageal strictures: experimental study in pigs and presentation of clinical cases. Radiology. 187, 667–671 (1993).
Tan, B. S. et al. Using uncovered metallic endoprostheses to treat recurrent benign esophageal strictures. AJR. Am. J. Roentgenol. 169, 1281–1284 (1997).

Supplementalinformation.docx

Download PDF

Editorial decision: Major revision
06 Apr, 2021
Reviews received at journal
22 Mar, 2021
Reviewers agreed at journal
17 Feb, 2021
Reviews received at journal
08 Feb, 2021
Reviewers agreed at journal
02 Feb, 2021
Reviewers invited by journal
02 Feb, 2021
Editor assigned by journal
25 Jan, 2021
Editor invited by journal
24 Dec, 2020
Submission checks completed at journal
24 Dec, 2020
First submitted to journal
22 Dec, 2020

You are reading this latest preprint version

Photothermal Therapy via a Gold Nanoparticle-Coated Stent for Treating Stent-Induced Granulation Tissue Formation in the Rat Esophagus

Status:

Version 1

Abstract

Figures

Introduction

Materials And Methods

Study design

Stent placement in the rat esophagus

Photothermal therapy under near-infrared irradiation

Histological analysis

Immunohistochemistry

Statistical analysis

Results

Histological findings

Discussion

Declarations

References

Supplementary Files

Status:

Version 1